Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Julphar
Federal Trade Commission
UBS
Fish and Richardson
Covington
Accenture
Farmers Insurance
Merck

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088791

« Back to Dashboard

NDA 088791 describes VASOCIDIN, which is a drug marketed by Novartis and is included in two NDAs. Additional details are available on the VASOCIDIN profile page.

The generic ingredient in VASOCIDIN is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.
Summary for 088791
Tradename:VASOCIDIN
Applicant:Novartis
Ingredient:prednisolone acetate; sulfacetamide sodium
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:OINTMENT;OPHTHALMICStrength0.5%;10%
Approval Date:Oct 5, 1984TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
AstraZeneca
Fuji
Covington
Chubb
Moodys
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.